Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xuezhikang for Dyslipidemia
NCT02057302Phase 4Completed
- Sponsor
- China Academy of Chinese Medical Sciences
- Start
- Mar 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of Xuezhikang in dyslipidemia, sponsored by China Academy of Chinese Medical Sciences. Started Mar 2010; status: completed.
02
Drugs
Xuezhikang
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT02057302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02057302.